rp 170 has been researched along with ku 2285 in 2 studies
| Studies (rp 170) | Trials (rp 170) | Recent Studies (post-2010) (rp 170) | Studies (ku 2285) | Trials (ku 2285) | Recent Studies (post-2010) (ku 2285) |
|---|---|---|---|---|---|
| 9 | 0 | 0 | 19 | 2 | 0 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, M; Oya, N; Sasai, K; Shibamoto, Y; Streffer, C | 1 |
| Streffer, C; Tamulevicius, P | 1 |
2 other study(ies) available for rp 170 and ku 2285
| Article | Year |
|---|---|
Radiosensitization efficacy of KU-2285, RP-170 and etanidazole at low radiation doses: assessment by in vitro cytokinesis-block micronucleus assay.
Topics: Animals; Cell Hypoxia; Dose-Response Relationship, Drug; Etanidazole; Mice; Micronucleus Tests; Nitroimidazoles; Nucleosides; Radiation Dosage; Radiation-Sensitizing Agents; Tumor Cells, Cultured | 1992 |
Metabolic studies and neurotoxicity in tumors and brain of mice after hypoxic cell sensitizers.
Topics: Adenosine Triphosphate; Animals; Brain; Etanidazole; Glucose; Male; Mice; Mice, Inbred C57BL; Misonidazole; Neoplasms, Experimental; Nitroimidazoles; Nucleosides; Radiation-Sensitizing Agents | 1994 |